Atlas Trials

Neostigmine Reversal And Neuromuscular Recovery

Clinical trial NCT02433808 · COMPLETED

Trial details

NCT number
NCT02433808
Sponsor
Endeavor Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Residual Neuromuscular Block
Start date
2015-04-01
Primary completion
2016-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.